This paper is a reflection on the meaning of the term "accountability", which is connected with the concepts of responsibility, trust and transparency. The authors present certain situations in pharmacology research that require responsibility of actions in conjunction with transparency of decision making. Various forms of conflicts of interest in financing the development of new drugs are discussed, including the risks connected with them and the problem of objectivity in decision making.

        Key words: Accountability; research ethics; ethics committees.